To investigate the prevalence of thyroid nodules (TNs) and to evaluate the association between TNs and metabolic syndrome (MetS) in the moderate iodine intake area of Jiangsu, China.
Subjects and Methods:
A cross-sectional study was carried out in a Chinese community-based epidemiological investigation from January to December 2014. A questionnaire was completed by 6494 subjects (2427 men and 4067 women). Thyroid ultrasound was performed by using a 7.5-MHz linear probe. MetS was defined according to the 2006 International Diabetes Federation criteria.
Results:
The prevalence of TNs in the study population was 17.7% (12.9% for men and 20.6% for women) and significantly higher in subjects with MetS [MetS(+)] than in those without MetS [MetS(−)] (25.8% vs. 15.5%, χ2 = 78.471, P < 0.001). Binary logistic regression indicated that (in addition to female sex and increased age) increased fasting plasma glucose (FPG), waist circumference (WC), hypertension, and smoking were positively associated with the prevalence of TNs.
Conclusions:
Our findings indicated a positive association between MetS and formation of TNs. Increased WC and FPG, as well as hypertension, might increase the prevalence of TNs.
Get full access to this article
View all access options for this article.
References
1.
TanGH, GharibH. Thyroid incidentalomas: Management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med, 1997; 126:226–231.
2.
KnudsenN, LaurbergP, PerrildH, et al.Risk factors for goiter and thyroid nodules. Thyroid, 2002; 12:879–888.
3.
CarleA, KrejbjergA, LaurbergP. Epidemiology of nodular goitre. Influence of iodine intake. Best Pract Res Clin Endocrinol Metab, 2014; 28:465–479.
4.
GharibH, PapiniE. Thyroid nodules: Clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am, 2007; 36:707–735, vi.
5.
RezzonicoJ, RezzonicoM, PusiolE, et al.Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid, 2008; 18:461–464.
6.
BrunnJ, BlockU, RufG, et al.Volumetric analysis of thyroid lobes by real-time ultrasound [in German]. Dtsch Med Wochenschr, 1981; 106:1338–1340.
7.
AlbertiKG, ZimmetP, ShawJ. Metabolic syndrome—A new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med, 2006; 23:469–480.
8.
YinJ, WangC, ShaoQ, et al.Relationship between the prevalence of thyroid nodules and metabolic syndrome in the iodine-adequate area of Hangzhou, China: A cross-sectional and cohort study. Int J Endocrinol, 2014; 2014:675796.
9.
AyturkS, GursoyA, KutA, et al.Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur J Endocrinol, 2009; 161:599–605.
10.
XuS, ChenG, PengW, et al.Oestrogen action on thyroid progenitor cells: Relevant for the pathogenesis of thyroid nodules. J Endocrinol, 2013; 218:125–133.
11.
KungAW, ChauMT, LaoTT, et al.The effect of pregnancy on thyroid nodule formation. J Clin Endocrinol Metab, 2002; 87:1010–1014.
12.
CostanteG, CrocettiU, SchifinoE, et al.Slow growth of benign thyroid nodules after menopause: No need for long-term thyroxine suppressive therapy in post-menopausal women. J Endocrinol Invest, 2004; 27:31–36.
13.
KnudsenN, BulowI, JorgensenT, et al.Goitre prevalence and thyroid abnormalities at ultrasonography: A comparative epidemiological study in two regions with slightly different iodine status. Clin Endocrinol (Oxf), 2000; 53:479–485.
14.
KnudsenN, PerrildH, ChristiansenE, et al.Thyroid structure and size and two-year follow-up of solitary cold thyroid nodules in an unselected population with borderline iodine deficiency. Eur J Endocrinol, 2000; 142:224–230.
15.
KnudsenN, LaurbergP, RasmussenLB, et al.Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab, 2005; 90:4019–4024.
16.
BastemirM, AkinF, AlkisE, et al.Obesity is associated with increased serum TSH level, independent of thyroid function. Swiss Med Wkly, 2007; 137:431–434.
17.
RosenbaumM, HirschJ, MurphyE, et al.Effects of changes in body weight on carbohydrate metabolism, catecholamine excretion, and thyroid function. Am J Clin Nutr, 2000; 71:1421–1432.
18.
SousaPA, VaismanM, CarneiroJR, et al.Prevalence of goiter and thyroid nodular disease in patients with class III obesity. Arq Bras Endocrinol Metabol, 2013; 57:120–125.
19.
PontikidesN, KrassasGE. Basic endocrine products of adipose tissue in states of thyroid dysfunction. Thyroid, 2007; 17:421–431.
20.
Zimmermann-BelsingT, BrabantG, HolstJJ, et al.Circulating leptin and thyroid dysfunction. Eur J Endocrinol, 2003; 149:257–271.
21.
XuY, WangL, HeJ, et al.Prevalence and control of diabetes in Chinese adults. JAMA, 2013; 310:948–959.
22.
AnilC, AkkurtA, AyturkS, et al.Impaired glucose metabolism is a risk factor for increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area. Metabolism, 2013; 62:970–975.
23.
JunikR, KozinskiM, Debska-KozinskaK. Thyroid ultrasound in diabetic patients without overt thyroid disease. Acta Radiol, 2006; 47:687–691.
24.
RapoportB, ChazenbalkGD, JaumeJC, et al.The thyrotropin (TSH) receptor: Interaction with TSH and autoantibodies. Endocr Rev, 1998; 19:673–716.
25.
VellaV, SciaccaL, PandiniG, et al.The IGF system in thyroid cancer: New concepts. Mol Pathol, 2001; 54:121–124.
26.
KimuraT, Van KeymeulenA, GolsteinJ, et al.Regulation of thyroid cell proliferation by TSH and other factors: A critical evaluation of in vitro models. Endocr Rev, 2001; 22:631–656.
27.
MohanS, BaylinkDJ, PettisJL. Insulin-like growth factor (IGF)-binding proteins in serum—Do they have additional roles besides modulating the endocrine IGF actions. J Clin Endocrinol Metab, 1996; 81:3817–3820.
